Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Bilal A. Siddiqui"'
Autor:
Patrick Discepola, Mohamed Bouhara, Minho Kwon, Bilal A. Siddiqui, Trevor A. Whitwell, Swetha Y. Sanghvi, Keith D. Cook, Ross E. Moore, Anna Korban, Jean D. Eloy
Publikováno v:
Pain Research and Management, Vol 2020 (2020)
EXPAREL® has been used successfully to prolong postoperative pain control when applied as a wound infiltrate. EXPAREL® has not yet been approved for use in regional anesthesia to prolong postoperative pain control. We conducted a clinical case seri
Externí odkaz:
https://doaj.org/article/c050e79e682a4ce6aa7801e399256494
Autor:
Eric C. Umbreit, Bilal A. Siddiqui, Michael J. Hwang, Aron Y. Joon, Tapati Maity, Mary E. Westerman, Kelly W. Merriman, Hussam Alhasson, Joma Uthup, Tao Guo, Joseph A. Moore, John F. Ward, Jose A. Karam, Christopher G. Wood, Louis L. Pisters, Miao Zhang, Shi-Ming Tu
Publikováno v:
Cancers, Vol 12, Iss 12, p 3755 (2020)
Although genetic changes may be pivotal in the origin of cancer, cellular context is paramount. This is particularly relevant in a progenitor germ cell tumor and its differentiated mature teratoma counterpart when it concerns tumor heterogeneity and
Externí odkaz:
https://doaj.org/article/16d11fd21a1046b59940fe4be67508fa
Autor:
Bilal A. Siddiqui, A.B., Vikram Jairam, B.S., Michele H. Johnson, M.D., David M. Greer, M.D., M.A., F.C.C.M., F.A.H.A.
Publikováno v:
Interdisciplinary Neurosurgery, Vol 1, Iss 4, Pp 81-83 (2014)
Moyamoya disease is a condition of the cerebrovascular system that involves stenosis of the intracranial internal carotid arteries as well as their proximal branches, often leading to stroke in affected patients. Here we describe the case of a patien
Externí odkaz:
https://doaj.org/article/88a6200f86bd436aa1dfd965dbe1a5ea
Autor:
Charles G Drake, Padmanee Sharma, Sumit K Subudhi, Patricia Troncoso, Sonali Jindal, Sreyashi Basu, Bilal A Siddiqui, Paul G Corn, Shalini S Yadav, Rebecca S S Tidwell, Christopher J Logothetis, Fei Duan, Brian F Chapin, Ai-Di Gu, Alexsandra B Espejo, Michelle Kinder, Curtis A Pettaway, John F Ward, Roland Knoblauch, Natalie Hutnick, Marco Gottardis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Background The prostate tumor microenvironment (TME) is immunosuppressive, with few effector T cells and enrichment of inhibitory immune populations, leading to limited responses to treatments such as immune checkpoint therapies (ICTs). The immune co
Externí odkaz:
https://doaj.org/article/872e2022f1224e93a2fad9d5033fcc27
Autor:
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, Bilal A. Siddiqui, Pratishtha Singh, Ashwat Nagarajan, Jielin Liu, Sumit K. Subudhi, Candice Poon, Kristal L. Gant, Shelley M. Herbrich, Swetha Anandhan, Shajedul Islam, Moran Amit, Gayathri Anandappa, James P. Allison
Publikováno v:
Cell. 186:1652-1669
Autor:
Padmanee Sharma, Swetha Anandhan, Bilal A. Siddiqui, Sangeeta Goswami, Sumit K. Subudhi, Jianjun Gao, Karl Peggs, Sergio Quezada, James P. Allison
Publikováno v:
Holland‐Frei Cancer Medicine. :1-22
Autor:
Andrew W Hahn, Bilal A Siddiqui, Javier Leo, Eleonora Dondossola, Kaitlin J Basham, Cindy K Miranti, Daniel E Frigo
Publikováno v:
Endocrinology.
Given the central role of the androgen receptor (AR) in prostate cancer cell biology, AR-targeted therapies have been the backbone of prostate cancer treatment for over 50 years. New data indicate that AR is expressed in additional cell types within
Autor:
Austin R Thomas, Cynthia Liu, Yi T Tong, Dongfeng Tan, Mehmet Altan, Bilal A Siddiqui, Anam Khan, Anusha S Thomas, Yinghong Wang
Purpose Immune checkpoint inhibitors (ICIs) are frequently associated with adverse events, often affecting the gastrointestinal tract. We conducted this study to determine the characteristics and outcomes of cancer patients with pre-existing microsco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f74484fb9911139116701ae563210eb
https://doi.org/10.21203/rs.3.rs-2030445/v1
https://doi.org/10.21203/rs.3.rs-2030445/v1
Autor:
Sangeeta, Goswami, Bilal A, Siddiqui, Sumit K, Subudhi, Sreyashi, Basu, Shalini S, Yadav, Adi, Diab, Padmanee, Sharma
Publikováno v:
Cancer Cell. 40:249-251
Finding biomarkers for predicting anti-tumor responses and immune-related adverse events (irAEs) with immune checkpoint therapy remains a challenge. Lozano et al. have developed a composite biomarker score that includes the frequency of effector-memo
Autor:
Jianjun Gao, Bilal A. Siddiqui, Swetha Anandhan, James P. Allison, Shalini S. Yadav, Padmanee Sharma, Sumit K. Subudhi, Sangeeta Goswami
Publikováno v:
Cancer Discovery. 11:838-857
Immune checkpoint therapy (ICT) can provide durable clinical responses and improve overall survival. However, only subsets of patients with specific tumor types respond to ICT. Thus, significant challenges remain, including understanding pathways of